Skip to main content
Erschienen in: Osteoporosis International 3/2019

15.12.2018 | Original Article

Administrative healthcare data applied to fracture risk assessment

verfasst von: S. Yang, W.D. Leslie, S.N. Morin, L.M. Lix

Erschienen in: Osteoporosis International | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Summary

Fracture risk scores generated from population-based administrative healthcare data showed comparable or better discrimination than the Fracture Risk Assessment Tool (FRAX) scores computed without bone mineral density for predicting incident major osteoporotic fracture. Administrative data may be useful to identify individuals at high fracture risk at the population level.

Purpose

To evaluate the discrimination of fracture risk scores defined using inputs available from administrative data for predicting incident major osteoporotic fracture (MOF) and hip fracture (HF) alone.

Methods

Using the Manitoba Bone Mineral Density (BMD) Database (1997–2013), we identified 61,041 individuals aged 50 years or older with healthcare coverage following their first BMD test. We calculated two-modified FRAX)scores based on administrative data: FRAX-A and FRAX-A+. The FRAX-A modification used all FRAX inputs, except for BMD, body mass index, and parental HF, while the FRAX-A+ modification using all FRAX-A inputs plus a comorbidity score, number of hospitalizations in the 3 years prior to the BMD test, depression diagnosis, and dementia diagnosis. FRAX scores computed with BMD (i.e., FRAX [BMD]) and without BMD (i.e., FRAX [no-BMD]) were the comparators.

Results

During a mean of 7 years of follow-up, we identified 5306 (8.7%) incident MOF and 1532 (2.5%) incident HF. The c-statistic for MOF associated with FRAX-A was lower than FRAX (BMD) (0.655 vs 0.675; P < 0.05) and comparable to FRAX (no-BMD) (0.654; P = 0.07). The c-statistic for MOF using FRAX-A+ (0.663) was lower than FRAX (BMD) but higher than FRAX (no-BMD) (both P < 0.05). For predicting incident HF, c-statistics associated with FRAX-A (0.762) and FRAX-A+ (0.767) were lower than FRAX (BMD) (0.789) and FRAX (no-BMD) (0.773; both P < 0.05).

Conclusions

FRAX-A and FRAX-A+ showed comparable or better discrimination than FRAX without BMD for predicting incident MOF, but slightly lower discrimination for HF alone.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Wiktorowicz ME, Goeree R, Papaioannou A, Adachi JD, Papadimitropoulos E (2001) Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporos Int 12:271–278CrossRefPubMed Wiktorowicz ME, Goeree R, Papaioannou A, Adachi JD, Papadimitropoulos E (2001) Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporos Int 12:271–278CrossRefPubMed
2.
Zurück zum Zitat Papaioannou A, Wiktorowicz ME, Adachi JD, Goeree R, Papadimitropoulos E, Bedard M (2000) Mortality, independence in living, and re-fracture, one year following hip fracture in Canadians. J Soc Obstet Gynaecol Can 22:591–597 Papaioannou A, Wiktorowicz ME, Adachi JD, Goeree R, Papadimitropoulos E, Bedard M (2000) Mortality, independence in living, and re-fracture, one year following hip fracture in Canadians. J Soc Obstet Gynaecol Can 22:591–597
3.
Zurück zum Zitat Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17:1726–1733CrossRefPubMed Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17:1726–1733CrossRefPubMed
4.
Zurück zum Zitat Tenenhouse A, Joseph L, Kreiger N, Poliquin S, Murray TM, Blondeau L, Berger C, Hanley DA, Prior JC, Grp CR (2000) Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian multicentre osteoporosis study (CaMos). Osteoporos Int 11:897–904CrossRefPubMed Tenenhouse A, Joseph L, Kreiger N, Poliquin S, Murray TM, Blondeau L, Berger C, Hanley DA, Prior JC, Grp CR (2000) Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian multicentre osteoporosis study (CaMos). Osteoporos Int 11:897–904CrossRefPubMed
5.
Zurück zum Zitat Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, Oden A, Zethraeus N, Pfleger B, Khaltaev N (2005) Assessment of fracture risk. Osteoporosis Int 16:581–589CrossRef Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, Oden A, Zethraeus N, Pfleger B, Khaltaev N (2005) Assessment of fracture risk. Osteoporosis Int 16:581–589CrossRef
6.
Zurück zum Zitat Kanis JA, Oden A, Johansson H, Borgstrom F, Strom O, McCloskey E (2009) FRAX and its applications to clinical practice. Bone 44:734–743CrossRefPubMed Kanis JA, Oden A, Johansson H, Borgstrom F, Strom O, McCloskey E (2009) FRAX and its applications to clinical practice. Bone 44:734–743CrossRefPubMed
7.
Zurück zum Zitat Shepstone L, Lenaghan E, Cooper C, Clarke S, Fong-Soe-Khioe R, Fordham R, Gittoes N, Harvey I, Harvey N, Heawood A, Holland R, Howe A, Kanis J, Marshall T, O'Neill T, Peters T, Redmond N, Torgerson D, Turner D, McCloskey E, Shepstone L, Lenaghan E, Cooper C, Clarke S, Fong-Soe-Khioe R, Fordham R, Gittoes N, Harvey I, Harvey N, Heawood A, Holland R, Howe A, Kanis J, Marshall T, O'Neill T, Peters T, Redmond N, Torgerson D, Turner D, McCloskey E, Crabtree N, Duffy H, Parle J, Rashid F, Stant K, Taylor K, Thomas C, Knox E, Tenneson C, Williams H, Adams D, Bion V, Blacklock J, Dyer T, Bratherton S, Fidler M, Knight K, McGurk C, Smith K, Young S, Collins K, Cushnaghan J, Arundel C, Bell K, Clark L, Collins S, Gardner S, Mitchell N (2018) Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. Lancet 391:741–747CrossRefPubMed Shepstone L, Lenaghan E, Cooper C, Clarke S, Fong-Soe-Khioe R, Fordham R, Gittoes N, Harvey I, Harvey N, Heawood A, Holland R, Howe A, Kanis J, Marshall T, O'Neill T, Peters T, Redmond N, Torgerson D, Turner D, McCloskey E, Shepstone L, Lenaghan E, Cooper C, Clarke S, Fong-Soe-Khioe R, Fordham R, Gittoes N, Harvey I, Harvey N, Heawood A, Holland R, Howe A, Kanis J, Marshall T, O'Neill T, Peters T, Redmond N, Torgerson D, Turner D, McCloskey E, Crabtree N, Duffy H, Parle J, Rashid F, Stant K, Taylor K, Thomas C, Knox E, Tenneson C, Williams H, Adams D, Bion V, Blacklock J, Dyer T, Bratherton S, Fidler M, Knight K, McGurk C, Smith K, Young S, Collins K, Cushnaghan J, Arundel C, Bell K, Clark L, Collins S, Gardner S, Mitchell N (2018) Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. Lancet 391:741–747CrossRefPubMed
8.
Zurück zum Zitat Ettinger B, Ensrud KE, Blackwell T, Curtis JR, Lapidus JA, Orwoll ES, Osteoporotic Fracture in Men Study Research G (2013) Performance of FRAX in a cohort of community-dwelling, ambulatory older men: the Osteoporotic Fractures in Men (MrOS) study. Osteoporos Int 24:1185–1193CrossRefPubMed Ettinger B, Ensrud KE, Blackwell T, Curtis JR, Lapidus JA, Orwoll ES, Osteoporotic Fracture in Men Study Research G (2013) Performance of FRAX in a cohort of community-dwelling, ambulatory older men: the Osteoporotic Fractures in Men (MrOS) study. Osteoporos Int 24:1185–1193CrossRefPubMed
9.
Zurück zum Zitat Briot K, Paternotte S, Kolta S, Eastell R, Felsenberg D, Reid DM, Gluer CC, Roux C (2013) FRAX(R): prediction of major osteoporotic fractures in women from the general population: the OPUS study. PLoS One 8:e83436CrossRefPubMedPubMedCentral Briot K, Paternotte S, Kolta S, Eastell R, Felsenberg D, Reid DM, Gluer CC, Roux C (2013) FRAX(R): prediction of major osteoporotic fractures in women from the general population: the OPUS study. PLoS One 8:e83436CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Kanis JA, Harvey NC, Johansson H, Oden A, Leslie WD, McCloskey EV (2015) FRAX and fracture prediction without bone mineral density. Climacteric 18(Suppl 2):2–9CrossRefPubMed Kanis JA, Harvey NC, Johansson H, Oden A, Leslie WD, McCloskey EV (2015) FRAX and fracture prediction without bone mineral density. Climacteric 18(Suppl 2):2–9CrossRefPubMed
11.
Zurück zum Zitat Reber KC, Konig HH, Becker C, Rapp K, Buchele G, Machler S, Lindlbauer I (2018) Development of a risk assessment tool for osteoporotic fracture prevention: a claims data approach. Bone 110:170–176CrossRefPubMed Reber KC, Konig HH, Becker C, Rapp K, Buchele G, Machler S, Lindlbauer I (2018) Development of a risk assessment tool for osteoporotic fracture prevention: a claims data approach. Bone 110:170–176CrossRefPubMed
12.
Zurück zum Zitat Rubin KH, Moller S, Holmberg T, Bliddal M, Sondergaard J, Abrahamsen B (2018) A new fracture risk assessment tool (FREM) based on public health registries. J Bone Miner Res 33:1967–1979CrossRefPubMed Rubin KH, Moller S, Holmberg T, Bliddal M, Sondergaard J, Abrahamsen B (2018) A new fracture risk assessment tool (FREM) based on public health registries. J Bone Miner Res 33:1967–1979CrossRefPubMed
13.
Zurück zum Zitat Leslie WD, Metge C (2003) Establishing a regional bone density program: lessons from the Manitoba experience. J Clin Densitom 6:275–282CrossRefPubMed Leslie WD, Metge C (2003) Establishing a regional bone density program: lessons from the Manitoba experience. J Clin Densitom 6:275–282CrossRefPubMed
14.
Zurück zum Zitat Leslie WD, Caetano PA, MacWilliam LR, Finlayson GS (2005) Construction and validation of a population-based bone densitometry database. J Clin Densitom 8:25–30CrossRefPubMed Leslie WD, Caetano PA, MacWilliam LR, Finlayson GS (2005) Construction and validation of a population-based bone densitometry database. J Clin Densitom 8:25–30CrossRefPubMed
15.
Zurück zum Zitat Lix LM, Azimaee M, Osman BA, Caetano P, Morin S, Metge C, Goltzman D, Kreiger N, Prior J, Leslie WD (2012) Osteoporosis-related fracture case definitions for population-based administrative data. BMC Public Health 12:301CrossRefPubMedPubMedCentral Lix LM, Azimaee M, Osman BA, Caetano P, Morin S, Metge C, Goltzman D, Kreiger N, Prior J, Leslie WD (2012) Osteoporosis-related fracture case definitions for population-based administrative data. BMC Public Health 12:301CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat O'Donnell S (2013) Use of administrative data for national surveillance of osteoporosis and related fractures in Canada: results from a feasibility study. Arch Osteoporos 8:143CrossRefPubMedPubMedCentral O'Donnell S (2013) Use of administrative data for national surveillance of osteoporosis and related fractures in Canada: results from a feasibility study. Arch Osteoporos 8:143CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA, Manitoba Bone Density P (2010) Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration. J Bone Miner Res 25:2350–2358CrossRefPubMed Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA, Manitoba Bone Density P (2010) Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration. J Bone Miner Res 25:2350–2358CrossRefPubMed
18.
Zurück zum Zitat Fraser LA, Langsetmo L, Berger C, Ioannidis G, Goltzman D, Adachi JD, Papaioannou A, Josse R, Kovacs CS, Olszynski WP (2011) Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos. Osteoporos Int 22:829–837CrossRefPubMed Fraser LA, Langsetmo L, Berger C, Ioannidis G, Goltzman D, Adachi JD, Papaioannou A, Josse R, Kovacs CS, Olszynski WP (2011) Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos. Osteoporos Int 22:829–837CrossRefPubMed
19.
Zurück zum Zitat Haller B, Schmidt G, Ulm K (2013) Applying competing risks regression models: an overview. Lifetime Data Anal 19:33–58CrossRefPubMed Haller B, Schmidt G, Ulm K (2013) Applying competing risks regression models: an overview. Lifetime Data Anal 19:33–58CrossRefPubMed
20.
Zurück zum Zitat Brier GW (1950) Verification of forecasts expressed in terms of probability. Mon Weather Rev 78:1–3CrossRef Brier GW (1950) Verification of forecasts expressed in terms of probability. Mon Weather Rev 78:1–3CrossRef
21.
Zurück zum Zitat Delong ER, Delong DM, Clarke-Pearson DL (1988) Comparing areas under two or more correlated reciever operating characteristics curves: a nonparamentric approach. Biometrics 44:837–845CrossRefPubMed Delong ER, Delong DM, Clarke-Pearson DL (1988) Comparing areas under two or more correlated reciever operating characteristics curves: a nonparamentric approach. Biometrics 44:837–845CrossRefPubMed
22.
Zurück zum Zitat Turner DA, Khioe RFS, Shepstone L, Lenaghan E, Cooper C, Gittoes N, Harvey NC, Holland R, Howe A, McCloskey E, O’Neill TW, Torgerson D, Fordham R, the SCOOP Study Team (2018) The cost-effectiveness of screening in the community to reduce osteoporotic fractures in older women in the UK: economic evaluation of the SCOOP study. J Bone Miner Res 33:845–851CrossRefPubMedPubMedCentral Turner DA, Khioe RFS, Shepstone L, Lenaghan E, Cooper C, Gittoes N, Harvey NC, Holland R, Howe A, McCloskey E, O’Neill TW, Torgerson D, Fordham R, the SCOOP Study Team (2018) The cost-effectiveness of screening in the community to reduce osteoporotic fractures in older women in the UK: economic evaluation of the SCOOP study. J Bone Miner Res 33:845–851CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Rubin KH, Rothmann MJ, Holmberg T, Høiberg M, Möller S, Barkmann R, Glüer CC, Hermann AP, Bech M, Gram J, Brixen K (2018) Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized risk-stratified osteoporosis strategy evaluation (ROSE) study. Osteoporos Int 29:567–578CrossRefPubMed Rubin KH, Rothmann MJ, Holmberg T, Høiberg M, Möller S, Barkmann R, Glüer CC, Hermann AP, Bech M, Gram J, Brixen K (2018) Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized risk-stratified osteoporosis strategy evaluation (ROSE) study. Osteoporos Int 29:567–578CrossRefPubMed
24.
Zurück zum Zitat Rothmann MJ, Moller S, Holmberg T et al (2017) Non-participation in systematic screening for osteoporosis-the ROSE trial. Osteoporos Int 28:3389–3399CrossRefPubMed Rothmann MJ, Moller S, Holmberg T et al (2017) Non-participation in systematic screening for osteoporosis-the ROSE trial. Osteoporos Int 28:3389–3399CrossRefPubMed
25.
Zurück zum Zitat Yang S, Leslie WD, Yan L, Walld R, Roos LL, Morin SN, Majumdar SR, Lix LM (2016) Objectively verified parental hip fracture is an independent risk factor for fracture: a linkage analysis of 478,792 parents and 261,705 offspring. J Bone Miner Res 31:1753–1759CrossRefPubMed Yang S, Leslie WD, Yan L, Walld R, Roos LL, Morin SN, Majumdar SR, Lix LM (2016) Objectively verified parental hip fracture is an independent risk factor for fracture: a linkage analysis of 478,792 parents and 261,705 offspring. J Bone Miner Res 31:1753–1759CrossRefPubMed
Metadaten
Titel
Administrative healthcare data applied to fracture risk assessment
verfasst von
S. Yang
W.D. Leslie
S.N. Morin
L.M. Lix
Publikationsdatum
15.12.2018
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 3/2019
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-018-4780-6

Weitere Artikel der Ausgabe 3/2019

Osteoporosis International 3/2019 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.